Journal article

Association of Aspirin and NSAID Use With Risk of Colorectal Cancer According to Genetic Variants

Hongmei Nan, Carolyn M Hutter, Yi Lin, Eric J Jacobs, Cornelia M Ulrich, Emily White, John A Baron, Sonja I Berndt, Hermann Brenner, Katja Butterbach, Bette J Caan, Peter T Campbell, Christopher S Carlson, Graham Casey, Jenny Chang-Claude, Stephen J Chanock, Michelle Cotterchio, David Duggan, Jane C Figueiredo, Charles S Fuchs Show all

JAMA | AMER MEDICAL ASSOC | Published : 2015

Grants

Awarded by National Cancer Institute (NCI), National Institutes of Health (NIH), US Department of Health and Human Services


Awarded by NIH


Awarded by NCI, NIH


Awarded by NIH: Australasian Colorectal Cancer Family Registry


Awarded by Ontario Registry for Studies of Familial Colorectal Cancer


Awarded by Seattle Colorectal Cancer Family Registry


Awarded by German Research Council (Deutsche Forschungsgemeinschaft)


Awarded by German Federal Ministry of Education and Research


Awarded by Ontario Research Fund


Awarded by National Heart, Lung, and Blood Institute, NIH, US Department of Health and Human Services



Funding Acknowledgements

GECCO (Genetics and Epidemiology of Colorectal Cancer Consortium) was supported by the National Cancer Institute (NCI), National Institutes of Health (NIH), US Department of Health and Human Services (U01 CA137088; RO1 CA059045). CCFR (Colon Cancer Family Registry) was supported by the NIH (RFA CA-95-011) and through cooperative agreements with members of the Colon Cancer Family Registry and prinicipal investigators. This genome wide scan was supported by the NCI, NIH, by U01 CA122839. The following Colon CFR centers contributed data to this manuscript and were supported by NIH: Australasian Colorectal Cancer Family Registry (U01 CA097735), Ontario Registry for Studies of Familial Colorectal Cancer (U01 CA074783), and Seattle Colorectal Cancer Family Registry (U01 CA074794). DACHS (Darmkrebs: Chancen der Verhutung durch Screening Study) is supported by the German Research Council (Deutsche Forschungsgemeinschaft, BR 1704/6-1, BR 1704163, BR 1704/6-4 and CH 117/1-1) and the German Federal Ministry of Education and Research (01KH0404 and 01ER0814). DALS (Diet, Activity and Lifestyle Study) is suported by the NIH (R01 CA48998 to Dr Slattery). HPFS (Health Professionals Follow-up Study) is supported by the NIH (P01 CA 055075, UM1 CA167552, R01137178, RO1 CA151993, and P50 CA 127003) and the NHS (Nurses Health Study) by the NIH (R01 CA137178, P01 CA 087969, RO1 CA151993, and P50 CA 127003). Dr Chan is also supported by K24 DK098311 and is a Damon Runyon Clinical Investigator. OFCCR (Ontario Familial Colorectal Cancer Registry) is supported by the NIH through funding allocated to the Ontario Registry for Studies of Familial Colorectal Cancer (U01 CA074783) (see CCFR section above). As subset of ARCTIC, OFCCR is supported by a GL2 grant from the Ontario Research Fund, the Canadian Institutes of Health Research, and the Cancer Risk Evaluation (CaRE) Program grant from the Canadian Cancer Society Research Institute. Dr Hudson and Dr Zanke are recipients of Senior Investigator Awards from the Ontario Institute for Cancer Research, through generous support from the Ontario Ministry of Research and Innovation. PLCO (Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial) is supported by the Intramural Research Program of the Division of Cancer Epidemiology and Genetics and by contracts from the Division of Cancer Prevention, NCI, NIH, Department of Health and Human Services. PMH-CCFR (Postmenopausal Hormone Study-Colon Cancer Family Registry) is suported by the NIH (R01 CA076366 to Dr Newcomb). VITAL (VITamins And Lifestyle) is supported by the NIH (K05 CA154337). WHI (Women's Health Initiative) is supported by the National Heart, Lung, and Blood Institute, NIH, US Department of Health and Human Services, through contracts HHSN268201100046C, HH5N268201100001C, HHSN268201100002C, HHSN268201100003C, HHSN268201100004C, and HHSN271201100004C.